Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 4, 2011, Pages 684-691

  Nebija, Dashnor ^a   Kopelent Frank, Hannelore ^a   Urban, Ernst ^a   Noe, Christian R ^a   Lachmann, Bodo ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

2 DE; MALDI TOF MS; PMF; Rituximab; Trastuzumab

Indexed keywords

CARBOXYPEPTIDASE B; LYSINE; RITUXIMAB; SIALIDASE; TRASTUZUMAB;

ARTICLE; DEGLYCOSYLATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; QUALITATIVE ANALYSIS; QUALITY CONTROL; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCOPROTEINS; HUMANS; OLIGOSACCHARIDES; PEPTIDE MAPPING; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84860408352     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.07.006     Document Type: Article

References (41)

1. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., Press M.F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
2. Hudis C.A. Trastuzumab-mechanism of action and use in clinical practice. N. Engl. J. Med. 2007, 357:39-51.
3. Harris R.J., Kabakoff B., Macchi F.D., Shen F.J., Kwong M., Andya J.D., Shire S.J., Bjork N., Totpal K., Chen A.B. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J. Chromatogr. B 2001, 752:233-245.
4. P.J. Carter, L.G. Presta, Method for making humanized antibodies. United States Patent, October 28, 2003. US patent no. 6,639,055, U.S. Patent and Trademark Office, Washington, DC. (accessed: 18.08.10). http://patft.uspto.gov/.
5. Reff M.E., Carner K., Chambers K.S., Chinn P.C., Leonard J.E., Raab R., Newman R.A., Hanna N., Anderson D.R. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody. Blood 1994, 83:435-445.
6. Du J., Wang H., Zhong C., Peng B., Zhang M., Li B., Hou S., Guo Y., Ding J. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide. Mol. Immunol. 2008, 45:2861-2868.
7. (accessed 10.09.10). http://www.ema.europa.eu/htms/human/epar/a.htm.
8. Wilkins M.R., Lindskog I., Gasteiger E., Bairoch A., Sanchez J.C., Hochstrasser D.F., Appel R.D. Detailed peptide characterisation using peptide mass-a World-Wide Web accessible tool. Electrophoresis 1997, 18:403-408.
9. Wan H.Z., Kaneshiro S., Frenz J., Cacia J. Rapid method for monitoring galactosylation levels during recombinant antibody production by electrospray mass spectrometry with selective-ion monitoring. J. Chromatogr. A 2001, 913:437-446.
10. Hodoniczky J., Zheng Y.Z., James D.J. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol. Prog. 2005, 21:1644-1652.
11. Noze M., Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1983, 80(21):6632-6636.
12. Kamoda S., Nomura C., Kinoshita M., Nishiura S., Ishikawa R., Kakehi K., Kawasaki N., Hayakawa T. Profiling analysis of oligosaccharides in antibody pharmaceuticals. J. Chromatogr. A 2004, 1050:211-216.
13. Kamoda S., Ishikawa R., Kakehi K. Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J. Chromatogr. A 2006, 1133:332-339.
14. Gennaro L.A., Salas-Solano O. On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. Anal. Chem. 2008, 80(10):3838-3845.
15. Ma S., Nashabeh W. Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection. Anal. Chem. 1999, 71(22):5185-5192.
16. Nakano M., Higo D., Arai E., Nakagawa T., Kakehi K., Taniguchi N., Kondo A. Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives. Glycobiology 2009, 19(2):135-143.
17. Stadlmann J., Pabst M., Kolarich D., Kunert R., Altmann F. Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8:2858-2871.
18. Kelly J.A., Lee C.S. On-line post-capillary affinity detection of immunoglobulin G subclasses and monoclonal antibody variants for capillary electrophoresis. J. Chromatogr. A 1997, 790:207-214.
19. Moorhouse K.G., Nashabeh W., Deveney J., Bjork N.S., Mulkerrin M.G., Ryscamp T. Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal antibody IDEC-C2B8 after papin digestion. J. Pharm. Biomed. Anal. 1997, 16:593-603.
20. Beum P.V., Kennedy A.D., Taylor R.P. Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas. J. Immunol. Methods 2004, 289:97-109.
21. Bookman M.A., Darcy K.M., Pearson D.C., Boothby R.A., Horowitz I.R. Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a Phase II Trial of the Gynecologic Oncology Group. J. Clin. Oncol. 2003, 21:283-290.
22. Stemmler H.J., Schmitt M., Willems A., Bernhard H., Harbeck N., Heinemann V. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier. Anticancer Drugs 2007, 18:23-28.
23. (accessed 10.09.10). http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
24. Carter P., Presta L., Gorman C.M., Ridgway J.B.B., Henner D., Wong W.L.T., Rowland A.M., Kotts C., Carver M.E., Shepard H.M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:233-245.
25. Damen C.W.N., Rosing H., Schellens J.H.M., Beijnen J.H. Quantitative aspects of the analysis of the monoclonal antibody using high-performance liquid chromatography coupled with electrospray mass spectrometry. J. Pharm. Biomed. Anal. 2008, 46:449-455.
26. Hunt G., Moorhouse K.G., Chen A.B. Capillary isoelectric focusing and sodium dodecyle sulfate capillary gel electrophoresis of recombinant humanized monoclonal; antibody HER2. J. Chromatogr. A 1996, 744:295-301.
27. Harris R.J. Processing of C-terminale lysine and arginine residues of proteins isolated from mammalian cell culture. J. Chromatogr. A 1995, 705:129-134.
28. Lam X.M., Jang J.Y., Cleland J.L. Antioxidants for prevention of metionone oxidation in recombinant monoclonal antoibody HER2. J. Pharm. Sci. 1997, 6:1250-1255.
29. Harris R.J., Murnane A.A., Utter S.L., Wagner K.L., Cox E.T., Polastry G.D., Helder J.C., Sliwkowski M.B. Assessing genetic heterogeneity in production of cell line: detection by peptide mapping of a low level Tyr to Gln Sequence variant in a recombinant antibody. Nat. Biotechnol. 1993, 11:1293-1297.
30. Henzel W.J., Watanabe C., Stults J.T. Protein identification: origins of peptide mass fingerprinting. J. Am. Soc. Mass Spectrom. 2003, 14:931-942.
31. Schlags W., Lachmann B., Walther M., Kratzel M., Noe C.R. Two-dimensional electrophoresis of recombinant human erythropoietin: a future method for the European Pharmacopoeia?. Proteomics 2002, 2:679-682.
32. Rabilloud T., Valette C., Lawrence J.J. Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis 1994, 15:1552-1558.
33. Görg A., Postel W., Günther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988, 9:531-546.
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970, 227:680-685.
35. Blum H., Beier H., Gross H.J. Improved silver staining of plant-proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8:93-99.
36. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 1996, 68(5):850-858.
37. Garahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., Mische S.M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605.
38. International Conference on Harmonization. Harmonized tripartite guideline. specifications: test procedures and acceptance criteria for biotechnological/biological products, Q6B. Step 5, Version March 1999. (accessed 18.08.10). http://www.ich.org/LOB/media/MEDIA432.pdf.
39. Raju T.S., Briggs J.B., Borge S.M., Jones A.S. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000, 10:477-486.
40. Perkins D.N., Pappin D.J.C., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
41. (accessed 18.08.10). http://prowl.rockefeller.edu/prowl-cgi/profound.exe.